Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation

被引:106
作者
Dehne, Tilo [1 ,2 ]
Karlsson, Camilla [3 ]
Ringe, Jochen [1 ,2 ]
Sittinger, Michael [1 ,2 ]
Lindahl, Anders [3 ]
机构
[1] Charite, Tissue Engn Lab, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
[2] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, D-10117 Berlin, Germany
[3] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Lab Med, SE-41345 Gothenburg, Sweden
关键词
HUMAN ARTICULAR CHONDROCYTES; ADULT STEM-CELLS; GENE-EXPRESSION; ENGINEERED CARTILAGE; BONE; PROLIFERATION; DEFECTS; GROWTH; KNEE; METALLOPROTEINASES;
D O I
10.1186/ar2800
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Introduction Autologous chondrocyte transplantation (ACT) is a routine technique to regenerate focal cartilage lesions. However, patients with osteoarthritis (OA) are lacking an appropriate long-lasting treatment alternative, partly since it is not known if chondrocytes from OA patients have the same chondrogenic differentiation potential as chondrocytes from donors not affected by OA. Methods Articular chondrocytes from patients with OA undergoing total knee replacement (Mankin Score > 3, Ahlback Score > 2) and from patients undergoing ACT, here referred to as normal donors (ND), were isolated applying protocols used for ACT. Their chondrogenic differentiation potential was evaluated both in high-density pellet and scaffold (Hyaff-11) cultures by histological proteoglycan assessment (Bern Score) and immunohistochemistry for collagen types I and II. Chondrocytes cultured in monolayer and scaffolds were subjected to gene expression profiling using genome-wide oligonucleotide microarrays. Expression data were verified by using real-time PCR. Results Chondrocytes from ND and OA donors demonstrated accumulation of comparable amounts of cartilage matrix components, including sulphated proteoglycans and collagen types I and II. The mRNA expression of cartilage markers (ACAN, COL2A1, COMP, CRTL1, SOX9) and genes involved in matrix synthesis (BGN, CILP2, COL9A2, COL11A1, TIMP4) was highly induced in 3D cultures of chondrocytes from both donor groups. Genes associated with hypertrophic or OA cartilage (ALPL, COL1A1, COL3A1, COL10A1, MMP13, POSTN, PTH1R, RUNX2) were not significantly regulated between the two groups of donors. The expression of 661 genes, including COMP, FN1, and SOX9, was differentially regulated between OA and ND chondrocytes cultured in monolayer. During scaffold culture, the differences diminished between the OA and ND chondrocytes, and only 184 genes were differentially regulated. Conclusions Only few genes were differentially expressed between OA and ND chondrocytes in Hyaff-11 culture. The risk of differentiation into hypertrophic cartilage does not seem to be increased for OA chondrocytes. Our findings suggest that the chondrogenic capacity is not significantly affected by OA, and OA chondrocytes fulfill the requirements for matrix-associated ACT.
引用
收藏
页数:14
相关论文
共 56 条
[1]
Gene expression and proliferation analysis in young, aged, and osteoarthritic sheep chondrocytes effect of growth factor treatment [J].
Acosta, Carlos A. ;
Izal, Inigo ;
Ripalda, Purificacion ;
Douglas-Price, Ana Laura ;
Forriol, Francisco .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2006, 24 (11) :2087-2094
[2]
Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO
[3]
2-A
[4]
INDEPENDENT EXPRESSION OF FIBRIL-FORMING COLLAGEN-I, COLLAGEN-II, AND COLLAGEN-III IN CHONDROCYTES OF HUMAN OSTEOARTHRITIC CARTILAGE [J].
AIGNER, T ;
BERTLING, W ;
STOSS, H ;
WESELOH, G ;
VONDERMARK, K .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :829-837
[5]
AIGNER T, 1995, LAB INVEST, V73, P236
[6]
Cartilage restoration, part 1 - Basic science, historical perspective, patient evaluation, and treatment options [J].
Alford, JW ;
Cole, BJ .
AMERICAN JOURNAL OF SPORTS MEDICINE, 2005, 33 (02) :295-306
[7]
First clinical experiences with a novel 3D-collagen gel (CaReS®) for the treatment of focal cartilage defects in the knee [J].
Andereya, S. ;
Maus, U. ;
Gavenis, K. ;
Mueller-Rath, R. ;
Miltner, O. ;
Mummel, T. ;
Schneider, U. .
ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2006, 144 (03) :272-280
[8]
Global analyses of gene expression in early experimental osteoarthritis [J].
Appleton, C. T. G. ;
Pitelka, V. ;
Henry, J. ;
Beier, F. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (06) :1854-1868
[9]
Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity [J].
Barbero, A ;
Grogan, S ;
Schäfer, D ;
Heberer, M ;
Mainil-Varlet, P ;
Martin, I .
OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (06) :476-484
[10]
Recommendations for indication and application of ACT of the joined advisory board of the German societies for Traumatology (DGU) and Orthopaedic Surgery (DGOOC) [J].
Behrens, P ;
Bosch, U ;
Bruns, J ;
Erggelet, C ;
Esenwein, SA ;
Gaissmaier, C ;
Krackhardt, T ;
Löhnert, J ;
Marlovits, S ;
Meenen, NM ;
Mollenhauer, J ;
Nehrer, S ;
Niethard, FU ;
Nöth, U ;
Perka, C ;
Richter, W ;
Schäfer, D ;
Schneider, U ;
Steinwachs, M ;
Weise, K .
ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 2004, 142 (05) :529-539